ChinaNorm

Works in Dermatology · Genetic & rare · Metabolic & endocrine · Neurology · Psychiatry

ChinaNorm is a clinical trial sponsor. It has 14 active clinical trials with 1,908 planned participants, across 5 therapeutic areas. Since 2021 it has completed 16 trials and stopped 0 early.

Trial track record · since 2021

14Active trials1,908 planned participants
16Completed0 with results posted
0Stopped early0% of finished trials

Pipeline · 14 active trials

StageTrialStatus

Questions about ChinaNorm

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-27.

Approve Suite is not affiliated with ChinaNorm.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.